Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8486329 | Vaccine | 2018 | 7 Pages |
Abstract
There is a dearth of prospective studies evaluating the risk of developing LRTI following influenza virus infection. Determining the burden of severe LRTI that is attributable to influenza is necessary to estimate the benefits of influenza vaccine on this important public health outcome. Vaccine probe studies are an efficient way to evaluate these questions and should be encouraged going forward.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ryan E. Malosh, Emily T. Martin, Justin R. Ortiz, Arnold S. Monto,